No coverage is required under §§ 58-17-100 to 58-17-106 , inclusive, for the following: (1) Any drug that has not been fully licensed or approved by the FDA; (2) The use of any drug if the FDA has determined that use to be contraindicated; or (3) Any experimental drug not otherwise approved for any indication by the FDA. Source: SL 2000, ch 242 , § 3.
Exceptions
SDCL § 58-17-102 — under HEALTH INSURANCE POLICIES.
SDCL § 58-17-102